🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to identify 1 or more doses of parenterally ad...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2024-03-21
Trial ID
NCT06310551
The purpose of this study is to investigate immunogenicity and safety of Me...
Status
Completed
Location
Celerion Belfast
Start Date
2018-08-22
Trial ID
NCT03635086
The purpose of this study is to evaluate the safety, reactogenicity, and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-22
Trial ID
NCT01659086
Treatments Being Tested
This is a randomized, observer-blinded, Phase 2 study evaluating the safety...
Status
Completed
Location
Paratus Clinical Research - Canberra
Start Date
2022-12-30
Trial ID
NCT05519839
The purpose of this study is to evaluate the safety and immunogenicity of H...
Status
Completed
Location
Emavundleni CRS
Start Date
2021-11-25
Trial ID
NCT05182125
The purpose of VAN00010 study is to assess the safety and immunogenicity of...
Status
Completed
Location
Accel Research Site - Birmingham Clinical Research Unit- Site Number : 8400080
Start Date
2023-10-31
Trial ID
NCT06128733
The purpose of this study is to further develop a formulation and dose regi...
Status
Completed
Location
Simon Williamson Clinic
Start Date
2016-02-01
Trial ID
NCT02661490
The primary purpose of this study is to assess the effect of Debio 4126 in ...
Status
Recruiting
Location
Cedars Sinai Medical Center
Start Date
2025-11-26
Trial ID
NCT06930625
Treatments Being Tested
The purpose of this first time in human (FTiH) study is to evaluate the saf...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-07-22
Trial ID
NCT01905215
The purpose of this study is to evaluate the safety and immunogenicity of 4...
Status
Not Yet Recruiting
Location
Soweto HVTN CRS
Start Date
2026-07-13
Trial ID
NCT06613789
Treatments Being Tested